Io Hayashi

No ORCID on file · 3 papers in corpus · active 2016-2025

Study types

  • article 3

Condition tags

  • endometriosis 2
  • endometrioma 2
article 2025
Clinical usefulness of E4-phytohemagglutinin reactive C4-binding protein relative front value in serum for distinguishing between ovarian clear cell adenocarcinoma and endometrioma
Clinica chimica acta; international journal of clinical chemistry ·doi:10.1016/j.cca.2025.120219

BACKGROUND AND AIMS: We identified a fully sialylated glycopeptide of the α-chain of Complement 4 binding protein (C4BP) in blood using Liquid chromatography/Mass spectrometry, which helps differentiate ovarian clear cell carcinoma (OCCC) f…

article 2022
Sensitive New Assay System for Serum Wisteria floribunda Agglutinin-Reactive Ceruloplasmin That Distinguishes Ovarian Clear Cell Carcinoma from Endometrioma
Analytical chemistry ·doi:10.1021/acs.analchem.1c04302

agglutinin (WFA)-reactive ceruloplasmin (CP) is a candidate marker for ovarian clear cell carcinoma (CCC) reported in our previous paper. Herein, a new measurement system was developed to investigate its potential as a serum marker for CCC.…

article 2016
IS-MW-1-3 A novel biomarker that distinguishes early stage ovarian clear cell adenocarcinomas from benign endometriomas(Group 1 Ovarian Cancer,International Session Mini Workshop)